Watchdog says benefits outweigh risks but that warning should be added to product information
Europe’s medicines regulator has found a possible link between Johnson & Johnson’s coronavirus vaccine and rare cases of unusual blood clotting disorders it said were “very similar” to those that had occurred with the AstraZeneca shot.
The European Medicines Agency (EMA) on Tuesday recommended a warning should be added to the vaccine’s product information, but stressed that the benefits of the shot – which was put on hold last week in Europe and the US – outweighed its risks.
Continue reading...from The Guardian https://ift.tt/3eg6S8x
